Antibodies to Enterovirus 71 (EV71) were evaluated in São Paulo State during 1999-2005. The titer of neutralizing antibodies against EV71 was determined by microneutralization assay, and a titer of ≥ 1:8 was defined as indicative of protected immunity. Neutralizing antibodies to EV71 were observed in 12.4% (55/442) of sera samples, a low protective rate, suggesting that EV71 infection is uncommon in this region, but that there is a relatively high susceptibility to EV71 related diseases, which is worrying considering the recent Asian outbreaks. Also, a significant location-specific difference in seropositivity was observed. Neutralizing antibodies to EV71 were observed in 8.7% (21/241) of São Paulo metropolitan area sera samples, and 16.9% (34/201) of the sera samples from other municipalities. A high number of Brazilian residents live in country and coastal areas without adequate access to piped water or sanitation. This situation may contribute to the EV71 dissemination in these zones. The analysis of environmental samples could possibly make a valuable contribution to studies on the epidemiology of EV71.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1590/s0036-46652010000600010 | DOI Listing |
J Surg Oncol
October 2024
Liver Surgery Unit, Department of Gastroenterology, Digestive Surgery Division, University of Saão Paulo Medical School, São Paulo, Brazil.
J Funct Biomater
March 2024
Bone Research Lab, Ribeiraão Preto School of Dentistry, University of Saão Paulo, Ribeiraão Preto 14040-904, SP, Brazil.
Bone tissue has a remarkable ability to regenerate following injury and trauma [...
View Article and Find Full Text PDFArq Bras Cardiol
March 2024
Universidade Federal do Vale do Saão Francisco - Colegiado de Medicina, Paulo Afonso, BA - Brasil.
Front Immunol
November 2023
Hospital Israelita Albert Einstein, São Paulo, Brazil.
Background: The frequency of antibodies in autoimmune encephalitis (AIE) may vary in different populations, however, data from developing countries are lacking. To describe the clinical profile of AIE in Brazil, and to evaluate seasonality and predictors of AIE in adult and pediatric patients.
Methods: We evaluated patients with possible AIE from 17 centers of the Brazilian Autoimmune Encephalitis Network (BrAIN) between 2018 and 2022.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!